贝康医疗(02170.HK) 公布,去年度未经审核收入约2.95亿至3.05亿元人民币,按年增长约41.8%至46.6%。集团指出,收入增加主要由于期内收购新加坡BMX Holdco后借助其覆盖全球的销售网络实现国内自主开发产品的国际销售,推动集团全球销售收入增长;集团成功开发重要的客户关系,例如在北美,集团与Gattaca Genomics订立买卖协议以出售Geri全时差培养箱,在中国集团与上海...
Source Link贝康医疗(02170.HK) 公布,去年度未经审核收入约2.95亿至3.05亿元人民币,按年增长约41.8%至46.6%。集团指出,收入增加主要由于期内收购新加坡BMX Holdco后借助其覆盖全球的销售网络实现国内自主开发产品的国际销售,推动集团全球销售收入增长;集团成功开发重要的客户关系,例如在北美,集团与Gattaca Genomics订立买卖协议以出售Geri全时差培养箱,在中国集团与上海...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.